AIDS Care journal: Ten years on, still out of reach: barriers to PrEP access and retention in France according to frontline actors (QualiPrEP study)

Study published in AIDS Care

PrEP for HIV has been available in France since 2014, and reimbursed since 2016, with general practitioners allowed to prescribe it since 2021. Despite these policy advances, uptake remains low among some of the most affected populations. The QualiPrEP study, a community-based qualitative study, explored barriers to PrEP access and retention ten years into its implementation.

Interviews were conducted with 28 PrEP frontline actors (healthcare professionals and community-based workers involved in promoting, prescribing, or supporting PrEP). The sample included one group discussion (n = 5), two triads (n = 6), two dyads (n = 4), and nine individual interviews (n = 13). Thematic analysis was inductive, with barriers classified across four main domains. Participants were mostly cisgender men, median age 48, born in France and abroad, and employed by NGOs in Paris. Thirteen barriers and four major themes emerged:

(1) Internal psychosocial barriers: lack of knowledge, negative health-related reactions; HIV stigma; STI risk perception, taboos;

(2) Internal pragmatic barriers: perceived limits of protection, usage and follow-up constraints;

(3) External psychosocial barriers: limited physician knowledge and reluctance;

(4) External pragmatic barriers: communication failures; structural constraints, lack of human and financial resources.

Findings, published in AIDS Care, call for more targeted messaging, simplified care models and provider training. They highlight the need to address social and symbolic dimensions of PrEP, with insights from those supporting users to ensure more equitable implementation.

Access full study results here.